HK1222652A1 - 取代的三唑並吡啶類 - Google Patents

取代的三唑並吡啶類

Info

Publication number
HK1222652A1
HK1222652A1 HK16110794.9A HK16110794A HK1222652A1 HK 1222652 A1 HK1222652 A1 HK 1222652A1 HK 16110794 A HK16110794 A HK 16110794A HK 1222652 A1 HK1222652 A1 HK 1222652A1
Authority
HK
Hong Kong
Prior art keywords
substituted triazolopyridines
triazolopyridines
substituted
Prior art date
Application number
HK16110794.9A
Other languages
English (en)
Inventor
Hartmut Schirok
Volker Schulze
Dirk Kosemund
Hans Briem
Benjamin Bader
Ulf Bmer
Antje Margret Wengner
Gerhard Siemeister
Philip Lienau
Original Assignee
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharma AG filed Critical Bayer Pharma AG
Publication of HK1222652A1 publication Critical patent/HK1222652A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK16110794.9A 2013-06-07 2016-09-13 取代的三唑並吡啶類 HK1222652A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13171039 2013-06-07
PCT/EP2014/061410 WO2014195274A1 (en) 2013-06-07 2014-06-03 Substituted triazolopyridines

Publications (1)

Publication Number Publication Date
HK1222652A1 true HK1222652A1 (zh) 2017-07-07

Family

ID=48570009

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16110794.9A HK1222652A1 (zh) 2013-06-07 2016-09-13 取代的三唑並吡啶類

Country Status (8)

Country Link
US (1) US9670202B2 (zh)
EP (1) EP3004092B1 (zh)
JP (1) JP2016520634A (zh)
CN (1) CN105408332B (zh)
CA (1) CA2914516A1 (zh)
ES (1) ES2626989T3 (zh)
HK (1) HK1222652A1 (zh)
WO (1) WO2014195274A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2966392T3 (es) 2015-04-17 2024-04-22 Crossfire Oncology Holding B V Biomarcadores pronósticos para quimioterapia inhibidora de TTK
JP7100125B2 (ja) 2017-10-27 2022-07-12 フレゼニウス・カビ・オンコロジー・リミテッド リボシクリブおよびその塩の改善された調製のためのプロセス
US12084453B2 (en) * 2021-12-10 2024-09-10 Incyte Corporation Bicyclic amines as CDK12 inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008290330A1 (en) * 2007-08-23 2009-02-26 Astrazeneca Ab 2-anilinopurin-8-ones as inhibitors of TTK/Mps1 for the treatment of proliferative disorders
JP6168773B2 (ja) * 2009-04-29 2017-07-26 バイエル・インテレクチュアル・プロパティ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＢａｙｅｒ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ ＧｍｂＨ 置換イミダゾキノキサリン
US9340528B2 (en) * 2009-09-04 2016-05-17 Bayer Pharma Aktiengesellschaft Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors
EP2343297A1 (en) * 2009-11-30 2011-07-13 Bayer Schering Pharma AG Triazolopyridines
PT2699575E (pt) * 2011-04-21 2015-07-29 Bayer Ip Gmbh Triazolopiridinas

Also Published As

Publication number Publication date
JP2016520634A (ja) 2016-07-14
WO2014195274A1 (en) 2014-12-11
US9670202B2 (en) 2017-06-06
CN105408332A (zh) 2016-03-16
CN105408332B (zh) 2017-05-10
EP3004092B1 (en) 2017-03-22
ES2626989T3 (es) 2017-07-26
EP3004092A1 (en) 2016-04-13
CA2914516A1 (en) 2014-12-11
US20160297811A1 (en) 2016-10-13

Similar Documents

Publication Publication Date Title
HK1222846A1 (zh) 取代的苄基吡唑
HK1221717A1 (zh) 取代的苄基吡唑
HK1221719A1 (zh) 芳基喹唑啉
EP3000028A4 (en) AUTOMATIC ADDING TO AN AGENDA
HRP20171890T1 (hr) Supstituirani imidazopiridazini
LT3016534T (lt) Pėdukė
GB201409640D0 (en) Quick-coupler
HK1223362A1 (zh) 取代的吡唑並吡啶胺
HK1220972A1 (zh) 取代的噻唑並嘧啶
IL246271A0 (en) Converted piperidinyl-tetrahydroquinolines
HK1222652A1 (zh) 取代的三唑並吡啶類
GB201310655D0 (en) Polydendrons
GB201313985D0 (en) Gskyfocuser
AU4899P (en) Herbie53 Iresine herbstii
GB201319648D0 (en) Gen-orator
GB201318786D0 (en) Gtifrsfaapp
GB201318654D0 (en) Holdlock
GB201317353D0 (en) Ed
GB201318304D0 (en) Ovenguard
HU4384U (en) Bullet-trap
AP00812S1 (en) Stumbelbloc
GB201313640D0 (en) Packccessories
GB201313646D0 (en) HarmicGo - harmonica
GB201312735D0 (en) Shortbelt
AP2013000703S (en) Adwura wura

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20210606